Reduce Hair Loss from Chemotherapy with Dignicap

Reduce Hair Loss from Chemotherapy with Dignicap

People facing chemotherapy have a lot to be stressed about. Now, hair loss may not be one of them due to the FDA approved cooling-cap called DigniCap.

It  consists of a snug-fitting silicone cooling cap connected to a cooling and control unit. Coolant circulates through channels in the cap. Sensors in the cap monitor scalp temperature allowing the system to automatically regulate cooling temperature throughout the treatment.

During each chemotherapy session, you wear the caps for 20 to 50 minutes before, during and after your chemotherapy session. The amount of time you wear the cap after the chemotherapy session depends on the type of chemotherapy you’re getting.

Because they are so cold,  the cold caps work by narrowing the blood vessels beneath the skin of the scalp, reducing the amount of chemotherapy medicine that reaches the hair follicles. With less chemotherapy medicine in the follicles, the hair may be less likely to fall out.

The cold also decreases the activity of the hair follicles, which slows down cell division and makes them less affected by the chemotherapy medicine.

Cold caps have been used in Europe since the 1970s, but until now, no cold cap has been approved by the U.S. Food and Drug Administration (FDA).

https://www.dignicap.com/how-it-works/

http://www.breastcancer.org/research-news/fda-approves-dignicap-in-us

 

Submit a Comment

Your email address will not be published. Required fields are marked *